{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:36:49Z","timestamp":1785379009506,"version":"3.55.0"},"reference-count":192,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cpcardiol.2025.103231","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:04:20Z","timestamp":1764259460000},"page":"103231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emerging risk factors for stroke and bleeding in patients with atrial fibrillation and heart failure\u2013a narrative review"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-2657","authenticated-orcid":false,"given":"Jan","family":"Zabierowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Hudzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.cpcardiol.2025.103231_bib0001","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and Risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0002","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.125.042586","article-title":"Atrial fibrillation, heart failure phenotypes, and mortality risk in the nationwide START registry: a propensity score matching analysis","volume":"14","author":"Menichelli","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2024.04.017","article-title":"Association between atrial fibrillation and heart failure patient reported outcomes across the ejection fraction spectrum","volume":"273","author":"Elkholey","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2017.07.056","article-title":"Risk of stroke in congestive heart failure with and without atrial fibrillation","volume":"248","author":"Kang","year":"2017","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0006","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2022.11.032","article-title":"Risks of heart failure, stroke, and bleeding in atrial fibrillation according to heart failure phenotypes","volume":"9","author":"Inciardi","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"36","key":"10.1016\/j.cpcardiol.2025.103231_bib0007","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"22","key":"10.1016\/j.cpcardiol.2025.103231_bib0009","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0011","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0012","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with Heart failure and reduced ejection fraction: a scientific statement from the American Heart Association","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41569-023-00857-3","article-title":"The bidirectional association between atrial fibrillation and myocardial infarction","volume":"20","author":"Frederiksen","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005155","article-title":"Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care","volume":"6","author":"Lane","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.cpcardiol.2025.103231_bib0016","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"18","key":"10.1016\/j.cpcardiol.2025.103231_bib0017","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.cpcardiol.2025.103231_bib0018","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0019","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jacc.2015.06.1314","article-title":"Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands","volume":"66","author":"Vermond","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0020","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hlc.2023.02.009","article-title":"Prevalence and prognostic implication of atrial fibrillation in heart failure subtypes: systematic review and meta-analysis","volume":"32","author":"Mundisugih","year":"2023","journal-title":"Heart Lung Circ"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0021","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0022","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ehf2.12260","article-title":"Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction","volume":"5","author":"Hohendanner","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","article-title":"Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction","volume":"146","author":"Reddy","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11897-024-00691-9","article-title":"Atrial fibrillation in heart failure: novel insights, challenges, and treatment opportunities","volume":"22","author":"Bidaoui","year":"2025","journal-title":"Curr Heart Fail Rep"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3390\/antiox13070806","article-title":"Effects of heart failure therapies on atrial fibrillation: biological and clinical perspectives","volume":"13","author":"Mauriello","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0026","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchf.2021.01.009","article-title":"Thromboembolism in heart failure patients in Sinus rhythm: epidemiology, pathophysiology, clinical trials, and future direction","volume":"9","author":"Lin","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0027","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ehf2.13091","article-title":"Risk of stroke in patients with heart failure and sinus rhythm: data from the Swedish Heart Failure Registry","volume":"8","author":"Hjalmarsson","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0028","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1002\/ejhf.3071","article-title":"Interaction of heart failure and stroke: a clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis","volume":"25","author":"Doehner","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0029","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0030","doi-asserted-by":"crossref","unstructured":"Saeed D., Fuenmayor D., Medina J.A.N., et al. Unraveling the paradox: can anticoagulation improve outcomes in patients with heart failure and increased bleeding risk? Published online 2024. doi:10.7759\/cureus.57544.","DOI":"10.7759\/cureus.57544"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.hfc.2010.03.002","article-title":"Pathophysiology of anemia in heart failure","volume":"6","author":"Anand","year":"2010","journal-title":"Heart Fail Clin"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0032","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10741-008-9088-8","article-title":"Heart failure and anemia: mechanisms and pathophysiology","volume":"13","author":"Anand","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0033","article-title":"Unraveling the paradox: can anticoagulation improve outcomes in patients with heart failure and increased bleeding risk?","author":"Saeed","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0034","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.clinthera.2014.07.015","article-title":"The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review","volume":"36","author":"Agarwal","year":"2014","journal-title":"Clin Ther"},{"issue":"753","key":"10.1016\/j.cpcardiol.2025.103231_bib0035","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.3399\/BJGP.2024.0470","article-title":"Stroke incidence in heart failure and atrial fibrillation: a population-based retrospective cohort study","volume":"75","author":"Jones","year":"2025","journal-title":"Br J Gen Pract"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0036","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1136\/openhrt-2024-002975","article-title":"Heart failure and major haemorrhage in people with atrial fibrillation","volume":"11","author":"Jones","year":"2024","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030499","article-title":"Optimal medical therapy for heart failure and integrated care in patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation long-term general registry","volume":"14","author":"Bonini","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030499","article-title":"Optimal medical therapy for heart failure and integrated care in patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation long-term general registry","volume":"14","author":"Bonini","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0039","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2018.04.093","article-title":"Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: the PREFER in AF - HF substudy","volume":"265","author":"Siller-Matula","year":"2018","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0041","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.hrthm.2024.02.048","article-title":"Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: a Taiwanese longitudinal cohort","volume":"21","author":"Cheng","year":"2024","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0042","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12872-024-04133-1","article-title":"Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"10050","key":"10.1016\/j.cpcardiol.2025.103231_bib0043","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(16)30968-0","article-title":"Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study","volume":"388","author":"Healey","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0044","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002975","article-title":"Heart failure and major haemorrhage in people with atrial fibrillation","volume":"11","author":"Jones","year":"2024","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007230","article-title":"Bleeding risk of direct oral anticoagulants in patients with heart failure and atrial fibrillation","volume":"14","author":"Jackevicius","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102739","article-title":"A closer look into gastrointestinal bleeding in heart failure patients","volume":"49","author":"Zaher","year":"2024","journal-title":"Curr Probl Cardiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0047","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/jcm8081240","article-title":"Patients with heart failure and preserved ejection fraction are at risk of gastrointestinal bleeding","volume":"8","author":"Schrutka","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.949726","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with heart failure and preserved, mildly reduced, and reduced ejection fraction: a systemic review and meta-analysis","volume":"9","author":"Wulamiding","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0049","first-page":"70","article-title":"Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin","volume":"114","author":"Kim","year":"2015","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0050","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.amjcard.2019.02.027","article-title":"Impact of heart failure type on thromboembolic and bleeding risk in patients with atrial fibrillation on oral anticoagulation","volume":"123","author":"Mentias","year":"2019","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0051","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ehf2.12256","article-title":"Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study","volume":"5","author":"Melgaard","year":"2018","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0052","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4070\/kcj.2014.44.5.281","article-title":"Stroke and bleeding risk in atrial fibrillation","volume":"44","author":"Senoo","year":"2014","journal-title":"Korean Circ J"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0053","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"38","author":"Zhu","year":"2015","journal-title":"Clin Cardiol"},{"issue":"7792","key":"10.1016\/j.cpcardiol.2025.103231_bib0054","first-page":"320","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0055","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3390\/ijms23031678","article-title":"SGLT2 inhibitors and their antiarrhythmic properties","volume":"23","author":"Kolesnik","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-024-02312-0","article-title":"The potential anti-arrhythmic effect of SGLT2 inhibitors","volume":"23","author":"Duan","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01105-5","article-title":"SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0058","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1097\/FJC.0000000000001183","article-title":"Association of SGLT2 inhibitors with risk of atrial fibrillation and stroke in patients with and without type 2 diabetes: a systemic review and meta-analysis of randomized controlled trials","volume":"79","author":"Zheng","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0059","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.21037\/jtd-22-550","article-title":"The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation\/atrial flutter in patients with type 2 diabetes mellitus\/heart failure: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2022","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","article-title":"Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction","volume":"77","author":"Santos-Gallego","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0061","doi-asserted-by":"crossref","first-page":"100","DOI":"10.14740\/jocmr4076","article-title":"Favorable effects of Sacubitril\/Valsartan on the peak atrial longitudinal strain in patients with chronic heart failure and a history of one or more episodes of atrial fibrillation: a retrospective cohort study","volume":"12","author":"De Vecchis","year":"2020","journal-title":"J Clin Med Res"},{"issue":"Supplement_2","key":"10.1016\/j.cpcardiol.2025.103231_bib0062","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.0926","article-title":"Sacubitril\/valsartan reduces atrial fibrillation and supraventricular arrhythmias in patients with HFrEF and remote monitoring: preliminary data from the SAVE THE RHYTHM","volume":"41","author":"Guerra","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0063","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.19102\/icrm.2022.130905","article-title":"The impact of angiotensin receptor\u2013neprilysin inhibitors on arrhythmias in patients with heart failure: a systematic review and meta-analysis","volume":"13","author":"Mujadzic","year":"2022","journal-title":"J Innov Card Rhythm Manag"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0064","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1146\/annurev-publhealth-031210-101211","article-title":"Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care","volume":"32","author":"Ford","year":"2011","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)31145-6","article-title":"Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"Supplement_1","key":"10.1016\/j.cpcardiol.2025.103231_bib0066","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.481","article-title":"Racial and ethnic disparities in the incidence of stroke and mortality in atrial fibrillation: a US nationwide study","volume":"45","author":"Essien","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101043","article-title":"Ethnic differences in atrial fibrillation in the United Kingdom","volume":"3","author":"Frimodt-M\u00f8ller","year":"2024","journal-title":"JACC Adv"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0068","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/STR.0b013e3182213e24","article-title":"Racial-ethnic disparities in stroke care: the American experience","volume":"42","author":"Cruz-Flores","year":"2011","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0069","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/jcm9092713","article-title":"Low body weight increases the risk of ischemic stroke and major bleeding in atrial fibrillation: the COOL-AF registry","volume":"9","author":"Krittayaphong","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0070","first-page":"1382","article-title":"[Impact of malnutrition on long-term mortality in outpatients with chronic heart failure]","volume":"34","author":"Bonilla-Palomas","year":"2017","journal-title":"Nutr Hosp"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0071","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/nutrit\/nuad108","article-title":"Prognostic impact of malnutrition in patients with coronary artery disease: a systematic review and meta-analysis","volume":"82","author":"He","year":"2024","journal-title":"Nutr Rev"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0072","first-page":"523","article-title":"Impact of diabetes, malnutrition and sarcopenia on the prognosis of patients admitted to internal medicine","volume":"223","author":"Galeano-Fern\u00e1ndez","year":"2023","journal-title":"Rev Cl\u00edn Esp (Engl Ed)"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00161","article-title":"Malnutrition in chronic kidney disease","volume":"6","author":"Iorember","year":"2018","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2024.100430","article-title":"Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation","volume":"29","author":"Soler-Espejo","year":"2025","journal-title":"J Nutr Health Aging"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0075","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.19102\/icrm.2023.14082","article-title":"Protein\u2013energy malnutrition is associated with worse outcomes in patients with atrial fibrillation: a nationwide analysis","volume":"14","author":"Markson","year":"2023","journal-title":"J Innov Card Rhythm Manag"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0076","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/europace\/euaa017","article-title":"Impact of malnutrition in the embolic\u2013haemorrhagic trade-off of elderly patients with atrial fibrillation","volume":"22","author":"Raposeiras-Roub\u00edn","year":"2020","journal-title":"EP Europace"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0077","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.numecd.2019.06.021","article-title":"Malnutrition status in patients of very advanced age with nonvalvular atrial fibrillation and its impact on clinical outcomes","volume":"29","author":"Cheng","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0078","first-page":"825","article-title":"Nutrition status, obesity and outcomes in patients with atrial fibrillation","volume":"75","author":"Raposeiras-Roub\u00edn","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"19","key":"10.1016\/j.cpcardiol.2025.103231_bib0079","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/nu15194195","article-title":"Role of malnutrition in atrial fibrillation: a prospective study including individuals \u2265 75 years of age","volume":"15","author":"G\u00f6\u00e7er","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0080","article-title":"The controlling nutritional status score and risk factors associated with malnutrition in patients with acute ischemic stroke","volume":"14","author":"Chen","year":"2023","journal-title":"Front Neurol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0081","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12620736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocrine Pract"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101468","article-title":"Associations of MAFLD and MAFLD subtypes with the risk of the incident myocardial infarction and stroke","volume":"49","author":"Chen","year":"2023","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0083","doi-asserted-by":"crossref","first-page":"207","DOI":"10.33963\/KP.a2023.0022","article-title":"Metabolic associated fatty liver disease and cardiovascular risk: the expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society","volume":"81","author":"Gorczyca-G\u0142owacka","year":"2023","journal-title":"Pol Heart J (Kardiol Polska)"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0084","article-title":"A systematic review and meta-analysis of cohort studies on the potential association between NAFLD\/MAFLD and risk of incident atrial fibrillation","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacasi.2023.08.003","article-title":"Association of metabolic dysfunction-associated fatty liver disease with risk of HF and AF","volume":"3","author":"Ohno","year":"2023","journal-title":"JACC Asia"},{"issue":"DEC","key":"10.1016\/j.cpcardiol.2025.103231_bib0086","article-title":"The interplay between obstructive sleep apnea and atrial fibrillation","volume":"8","author":"Marulanda-Londo\u00f1o","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0087","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2020.01.001","article-title":"Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation","volume":"223","author":"Dalgaard","year":"2020","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0088","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjcard.2014.11.027","article-title":"Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation","volume":"115","author":"Yaranov","year":"2015","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0089","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0971-4065.202405","article-title":"Stroke in patients with chronic kidney disease\u2026: how do we approach and manage it?","volume":"27","author":"Nayak-Rao","year":"2017","journal-title":"Indian J Nephrol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0090","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the ATRIA study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266046","article-title":"Chronic kidney disease and atrial fibrillation: a dangerous combination","volume":"17","author":"Ocak","year":"2022","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2024.12.008","article-title":"Stroke in heart failure with reduced ejection fraction: systematic review and meta-analysis of randomized trials","volume":"13","author":"Gallone","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0093","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cardfail.2023.02.009","article-title":"Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society","volume":"29","author":"Tsutsui","year":"2023","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0094","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/STROKEAHA.118.023218","article-title":"NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the risk of stroke: results from the biomarcare consortium","volume":"50","author":"Di Castelnuovo","year":"2019","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.cpcardiol.2025.103231_bib0095","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.123.064361","article-title":"Effects of atrial fibrillation screening according to N-terminal Pro-B-type natriuretic peptide: a secondary analysis of the randomized LOOP study","volume":"147","author":"Xing","year":"2023","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.cpcardiol.2025.103231_bib0096","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024302","article-title":"Usefulness of B-type natriuretic peptide for predicting the risk of stroke in patients with heart failure with preserved ejection fraction","volume":"11","author":"Liu","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"42","key":"10.1016\/j.cpcardiol.2025.103231_bib0097","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1093\/eurheartj\/ehac487","article-title":"Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation","volume":"43","author":"Kondo","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0098","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/ehf2.12818","article-title":"B-type natriuretic peptide is associated with post-discharge stroke in hospitalized patients with heart failure","volume":"7","author":"Hotsuki","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0099","first-page":"e8","article-title":"Value of N-terminal pro-brain natriuretic peptide for embolic events risk prediction in patients with atrial fibrillation; a systematic review and meta-analysis","volume":"11","author":"Ahmadzadeh","year":"2023","journal-title":"Arch Acad Emerg Med"},{"issue":"22","key":"10.1016\/j.cpcardiol.2025.103231_bib0100","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","article-title":"N-Terminal Pro\u2013B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE trial (Apixaban for the prevention of stroke in subjects with atrial fibrillation)","volume":"61","author":"Hijazi","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0101","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamacardio.2016.3311","article-title":"Cardiovascular biomarker score and clinical outcomes in patients with atrial fibrillation: a subanalysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"1","author":"Ruff","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/STROKEAHA.113.003338","article-title":"Usefulness of N- terminal pro-B- type natriuretic peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation","volume":"45","author":"Rold\u00e1n","year":"2014","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0103","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1253\/circj.CJ-17-1155","article-title":"Incidence and risk factors of stroke or systemic embolism in patients with atrial fibrillation and heart failure - the Fushimi AF Registry","volume":"82","author":"Iguchi","year":"2018","journal-title":"Circ J"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0104","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/heartjnl-2020-317735","article-title":"Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure","volume":"107","author":"Hamatani","year":"2021","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jacc.2013.07.093","article-title":"High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin","volume":"63","author":"Hijazi","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/CIRCULATIONAHA.113.006286","article-title":"High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"129","author":"Hijazi","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0107","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/STROKEAHA.119.028323","article-title":"Association between high-sensitivity cardiac troponin and risk of stroke in 96702 individuals: a meta-analysis","volume":"51","author":"Broersen","year":"2020","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0108","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/jth.12638","article-title":"D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation\u2013observations from the ARISTOTLE trial","volume":"12","author":"Christersson","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41565","article-title":"Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?","volume":"7","author":"Garc\u00eda-Fern\u00e1ndez","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0110","article-title":"Association of Fibrinogen with ischemic stroke: a systematic review and meta-analysis","volume":"15","author":"Prasad","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0111","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2024.09.011","article-title":"Oxidative stress and atrial fibrillation","volume":"196","author":"Pfenniger","year":"2024","journal-title":"J Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0112","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1089\/ars.2013.5542","article-title":"Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibition with statins","volume":"20","author":"Pinho-Gomes","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0113","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ahj.2015.09.018","article-title":"Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation","volume":"170","author":"Aulin","year":"2015","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.cpcardiol.2025.103231_bib0114","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejim.2017.07.028","article-title":"Association between red cell distribution width and thromboembolic events in patients with atrial fibrillation","volume":"46","author":"Cha","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103231_bib0116","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/jth.13006","article-title":"Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study","volume":"13","author":"Saliba","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0117","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12872-020-01525-x","article-title":"Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation","volume":"20","author":"Zheng","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0118","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.118.035411","article-title":"Refining prediction of atrial fibrillation-related stroke using the P2-CHA2DS2-VASc score: the Atherosclerosis Risk in Communities (ARIC) study and multi-ethnic Study of atherosclerosis (MESA)","volume":"139","author":"Maheshwari","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0119","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/STROKEAHA.117.017084","article-title":"Stratifying stroke risk in atrial fibrillation: beyond clinical risk scores","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0121","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","article-title":"Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the fushimi atrial fibrillation registry","volume":"46","author":"Takabayashi","year":"2015","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.cpcardiol.2025.103231_bib0122","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0123","doi-asserted-by":"crossref","first-page":"939","DOI":"10.12998\/wjcc.v10.i3.939","article-title":"Atrial fibrillation burden and the risk of stroke: a systematic review and dose-response meta-analysis","volume":"10","author":"Yang","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0124","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fneur.2020.00026","article-title":"Left atrial enlargement and the risk of stroke: a meta-analysis of prospective cohort studies","volume":"11","author":"Xu","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0125","doi-asserted-by":"crossref","DOI":"10.1038\/srep31042","article-title":"Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation","volume":"6","author":"Hamatani","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0126","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","article-title":"Left atrial size and the risk of stroke and death. The Framingham heart study","volume":"92","author":"Benjamin","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0127","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","article-title":"Left atrial enlargement and stroke recurrence: the Northern Manhattan stroke study","volume":"46","author":"Yaghi","year":"2015","journal-title":"Stroke J Cereb Circ"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103231_bib0128","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jacc.2017.07.758","article-title":"Left atrial fibrosis and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation","volume":"70","author":"King","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2025.103231_bib0129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","article-title":"Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study","volume":"60","author":"Di Biase","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4022\/jafib.2183","article-title":"Left atrial appendage morphology as a determinant for stroke risk assessment in atrial fibrillation patients: systematic review and meta-analysis","volume":"12","author":"Anan","year":"2019","journal-title":"J Atr Fibrillation"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0131","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0735-1097(94)90025-6","article-title":"Prognostic implications of left artial spontaneous echo contrast in nonvalvular atrial fibrillation","volume":"24","author":"Leung","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0132","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0735-1097(00)00643-4","article-title":"Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm","volume":"35","author":"Sadanandan","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0133","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/STROKEAHA.116.013351","article-title":"Poor outcome of stroke patients with atrial fibrillation in the presence of coexisting spontaneous echo contrast","volume":"47","author":"Yoo","year":"2016","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0134","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1161\/STROKEAHA.117.017574","article-title":"Echocardiographic risk factors for stroke and outcomes in patients with atrial fibrillation anticoagulated with apixaban or warfarin","volume":"48","author":"Vinereanu","year":"2017","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ehjqcco\/qcaa003","article-title":"Association of relative wall thickness of left ventricle with incidence of thromboembolism in patients with non-valvular atrial fibrillation: the Fushimi AF Registry","volume":"6","author":"Tezuka","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1-2","key":"10.1016\/j.cpcardiol.2025.103231_bib0136","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2008.04.006","article-title":"Tissue doppler index, E\/E\u2019, and ischemic stroke in patients with atrial fibrillation and preserved left ventricular ejection fraction","volume":"271","author":"Lee","year":"2008","journal-title":"J Neurol Sci"},{"issue":"20","key":"10.1016\/j.cpcardiol.2025.103231_bib0137","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28034","article-title":"Prediction of atrial fibrillation and stroke using machine learning models in UK Biobank","volume":"10","author":"Papadopoulou","year":"2024","journal-title":"Heliyon"},{"issue":"17","key":"10.1016\/j.cpcardiol.2025.103231_bib0139","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.114.013760","volume":"131","author":"Abdul-Rahim","year":"2015","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010377","article-title":"Predicting stroke in heart failure and preserved ejection fraction without atrial fibrillation","volume":"16","author":"Kondo","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0141","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0142","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017157","article-title":"Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation","volume":"7","author":"Fox","year":"2017","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0143","first-page":"888","article-title":"A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"38","author":"Fanola","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0144","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ckj\/sfv006","article-title":"Advanced chronic kidney disease in non-valvular atrial fibrillation: extending the utility of R2CHADS2 to patients with advanced renal failure","volume":"8","author":"Bautista","year":"2015","journal-title":"Clin Kidney J"},{"issue":"11","key":"10.1016\/j.cpcardiol.2025.103231_bib0145","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/europace\/euac020","volume":"24","author":"Gorog","year":"2022","journal-title":"EP Europace"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0146","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.49017","article-title":"Risk of intracranial hemorrhage associated with direct oral anticoagulation vs antiplatelet therapy: a systematic review and meta-analysis","volume":"7","author":"Coyle","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0147","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2024.02.014","article-title":"Patterns of atrial fibrillation anticoagulation with rivaroxaban\u20137-year follow-up from the Dresden NOAC registry","volume":"236","author":"Tittl","year":"2024","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0148","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0149","first-page":"783","article-title":"Age as a risk factor for stroke in atrial fibrillation patients: implications in thromboprophylaxis in the era of novel oral anticoagulants","volume":"6","author":"Mitrousi","year":"2013","journal-title":"J Atr Fibrillation"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0150","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"Hankey","year":"2014","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0151","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O\u2019Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0152","article-title":"Frailty and risk of gastrointestinal bleeding: a prospective cohort study based on UK biobank","volume":"13","author":"Zhang","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101527","article-title":"Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: a meta-analysis","volume":"73","author":"He","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"issue":"Supplement_2","key":"10.1016\/j.cpcardiol.2025.103231_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.635","article-title":"Multimorbidity, frailty and malnutrition: moving beyond traditional risk factors for risk assessment in atrial fibrillation. The Murcia Atrial Fibrillation Project II","volume":"43","author":"Rivera-Caravaca","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0156","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jjcc.2016.06.014","article-title":"Clinical significance of nutritional status in patients with atrial fibrillation: an overview of current evidence","volume":"69","author":"Anaszewicz","year":"2017","journal-title":"J Cardiol"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0157","first-page":"825","article-title":"Nutrition status, obesity and outcomes in patients with atrial fibrillation","volume":"75","author":"Raposeiras-Roub\u00edn","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0158","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.103794","article-title":"Predictive value of nutritional scores in non-valvular atrial fibrillation patients: insights from the AFTER-2 study","volume":"35","author":"S\u00f6ner","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0159","doi-asserted-by":"crossref","DOI":"10.1111\/anec.13130","article-title":"Effect of nutritional status on adverse clinical events in elderly patients with nonvalvular atrial fibrillation: a retrospective cohort study","volume":"29","author":"Zhang","year":"2024","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jjcc.2020.10.008","article-title":"Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants","volume":"77","author":"Shinohara","year":"2021","journal-title":"J Cardiol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0161","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.clnu.2020.10.002","article-title":"Severe undernutrition increases bleeding risk on vitamin-K antagonists","volume":"40","author":"Moustafa","year":"2021","journal-title":"Clin Nutr"},{"issue":"14","key":"10.1016\/j.cpcardiol.2025.103231_bib0162","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13144215","article-title":"Impact of malnutrition on the outcomes in patients admitted with heart failure","volume":"13","author":"Bansal","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0163","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ehf2.14631","article-title":"Geriatric Nutritional Risk Index predicts bleeding event in patients with heart failure","volume":"11","author":"Sato","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0164","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.hrthm.2016.12.036","article-title":"Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants","volume":"14","author":"Park","year":"2017","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.cpcardiol.2025.103231_bib0165","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/jcm9092713","article-title":"Low body weight increases the risk of ischemic stroke and major bleeding in atrial fibrillation: the COOL-AF registry","volume":"9","author":"Krittayaphong","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0166","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/clc.23593","article-title":"The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis on the obesity paradox","volume":"44","author":"Grymonprez","year":"2021","journal-title":"Clin Cardiol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2025.103231_bib0167","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/jth.13701","article-title":"Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis","volume":"15","author":"Boonyawat","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0168","article-title":"From first slip to second setback: intracranial injury risk after recurrent falls in older adults: a retrospective cohort study","volume":"7","author":"Namoos","year":"2025","journal-title":"Adv Geriatr Med Res"},{"issue":"10","key":"10.1016\/j.cpcardiol.2025.103231_bib0169","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.amjmed.2014.05.035","article-title":"Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project","volume":"127","author":"Banerjee","year":"2014","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.cpcardiol.2025.103231_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.amjmed.2012.01.033","article-title":"Risk of falls and major bleeds in patients on oral anticoagulation therapy","volume":"125","author":"Donz\u00e9","year":"2012","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0171","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102908","article-title":"Risk of major bleeding in recurrent fallers receiving anticoagulation for atrial fibrillation: a prospective cohort study","volume":"9","author":"Regina","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0172","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2020.08.028","article-title":"Cognitive impairment in patients with atrial fibrillation: implications for outcome in a cohort study","volume":"323","author":"Malavasi","year":"2021","journal-title":"Int J Cardiol"},{"issue":"15","key":"10.1016\/j.cpcardiol.2025.103231_bib0173","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1007\/s11606-022-07410-x","article-title":"Presence of geriatric conditions is prognostic of major bleeding in older patients with atrial fibrillation: a cohort study","volume":"37","author":"Wang","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0174","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","article-title":"Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation","volume":"211","author":"Madhavan","year":"2019","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCOUTCOMES.109.884171","article-title":"Cognitive function and anticoagulation control in patients with atrial fibrillation","volume":"3","author":"Flaker","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.cpcardiol.2025.103231_bib0176","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001257","article-title":"Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis","volume":"7","author":"Gallagher","year":"2020","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0177","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11739-022-03156-w","article-title":"Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis","volume":"18","author":"Pastori","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0178","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022478","article-title":"Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)","volume":"9","author":"Rohla","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103231_bib0179","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002489","article-title":"BNP level predicts bleeding event in patients with heart failure after percutaneous coronary intervention","volume":"10","author":"Otsuka","year":"2023","journal-title":"Open Heart"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2018-313642","article-title":"B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation","volume":"105","author":"Inohara","year":"2019","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.cpcardiol.2025.103231_bib0181","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013560","article-title":"Cardiac biomarkers and subsequent risk of hospitalization with bleeding in the community: atherosclerosis risk in communities study","volume":"9","author":"Mathews","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10.1016\/j.cpcardiol.2025.103231_bib0182","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","article-title":"Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy","volume":"125","author":"Hijazi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0183","first-page":"81","article-title":"Cardiac injury, maladaptation, and heart failure incidence","author":"Milks","year":"2018","journal-title":"Biomark Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0184","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2017.06.001","article-title":"Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"190","author":"Hijazi","year":"2017","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.cpcardiol.2025.103231_bib0185","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"issue":"10035","key":"10.1016\/j.cpcardiol.2025.103231_bib0186","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.cpcardiol.2025.103231_bib0187","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2010.12.033","article-title":"Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients","volume":"57","author":"Rold\u00e1n","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103231_bib0188","article-title":"Diagnostic accuracy of the HAS-BLED bleeding score in VKA-or DOAC-treated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"Gao","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.cpcardiol.2025.103231_bib0189","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.cpcardiol.2025.103231_bib0190","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the AnTicoagulation and risk factors In atrial fibrillation (ATRIA) study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"46","key":"10.1016\/j.cpcardiol.2025.103231_bib0191","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"O\u2019Brien","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103231_bib0192","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/CIRCULATIONAHA.123.064556","article-title":"Development and validation of the DOAC score: a novel bleeding risk prediction tool for patients with atrial fibrillation on direct-acting oral anticoagulants","volume":"148","author":"Aggarwal","year":"2023","journal-title":"Circulation"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:32:54Z","timestamp":1769592774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":192,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0146280625002506"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103231","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging risk factors for stroke and bleeding in patients with atrial fibrillation and heart failure\u2013a narrative review","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103231"}}